Value Signal · ACO & Population Health edition
Tuesday, November 3, 2026
4 stories on value-based care, payment and policy, ranked by relevance. Past 48 hours · as of Nov 3, 6:00 AM ET.
Top story for you
10 Things Hospital Leaders Need to Know About CJR-X
PremierCMMI modelsTopic alignment 94
As hospitals prepare for CJR-X, understanding financial risk, evaluating historical performance and strengthening care coordination will be essential to succeeding under the new mandatory bundled payment model.
Most-Favored-Nation Drug Pricing Framework: How Manufacturer Agreements Affect Medicaid Best Price, Contracts, and Compliance
Frier LevittTopic alignment 88
The White House announced on August 31, 2026, that nine additional pharmaceutical manufacturers had signed most-favored-nation (MFN) pricing agreements with the federal government. The new signatories include Alcon, Astellas Pharma, BeOne Medicines,…
CJR-X: Why a Population Health Strategy Is Essential
Forvis MazarsTopic alignment 90
Why CAHPS still swings Star Ratings at half its old weight
MarketScaleTopic alignment 88
Quiet in this window: Value-based contracting, MSSP & ACO operations, Risk adjustment & RADV, Population health & care management.
This edition follows the ACO & Population Health topics: Value-based contracting, CMMI models, MSSP & ACO operations, Risk adjustment & RADV, Population health & care management, Quality measurement & performance. Other roles, and your own mix of topics, are in Customize my Signal.